IDL Biotech AB (XSAT:IDL) 3-Year Revenue Growth Rate : -33.70% (As of Jun. 2021)

View and export this data going back to 2004. Start your Free Trial

What is IDL Biotech AB 3-Year Revenue Growth Rate?

IDL Biotech AB's Revenue per Share for the three months ended in Jun. 2021 was kr0.10.

During the past 12 months, IDL Biotech AB's average Revenue per Share Growth Rate was -24.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was -33.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was -15.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 0.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of IDL Biotech AB was 21.60% per year. The lowest was -33.70% per year. And the median was 4.95% per year.

Competitive Comparison of IDL Biotech AB's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, IDL Biotech AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDL Biotech AB's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Biotech AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where IDL Biotech AB's 3-Year Revenue Growth Rate falls into.

IDL Biotech AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

IDL Biotech AB (XSAT:IDL) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

IDL Biotech AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

IDL Biotech AB (XSAT:IDL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Biotech AB (XSAT:IDL) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Karlsbodavagen 39, Stockholm, SWE

Website

http://www.idl.se

IDL Biotech AB develops, produces and markets In Vitro Diagnostic tests for the health care sector. It offers in vitro diagnostic tests within the clinical areas of oncology and bacteriology. The company's trademark products includes TUBEX, TPS, UBC, MonoTotal and TPAcyk.

IDL Biotech AB (XSAT:IDL) Headlines

No Headlines